Original Research
Accepted on 15 May 2026
Phillygenin suppresses hepatocellular carcinoma progression by modulating the TNF signaling pathway and TCA cycle metabolism
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 15 May 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 15 May 2026
in Human and Medical Genomics
Original Research
Accepted on 15 May 2026
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Review
Accepted on 15 May 2026
in Diabetes: Molecular Mechanisms
Original Research
Accepted on 15 May 2026
in Multi- and Hyper-Spectral Imaging
Original Research
Accepted on 15 May 2026
in Land, Livelihoods and Food Security
Original Research
Accepted on 15 May 2026
in Coastal Ocean Processes
Systematic Review
Accepted on 15 May 2026
in Intensive Care Medicine and Anesthesiology
Original Research
Accepted on 15 May 2026
in Clinical Diabetes
Original Research
Accepted on 15 May 2026
in Health Informatics
Review
Accepted on 15 May 2026
in Stem Cell Research
Opinion
Accepted on 15 May 2026
in Phylogenetics, Phylogenomics, and Systematics
Review
Accepted on 15 May 2026
in Microbial Immunology
Original Research
Accepted on 15 May 2026
in Computational Physiology and Medicine
Original Research
Accepted on 15 May 2026
in Clinical Nutrition
Original Research
Accepted on 15 May 2026
in Geriatric Medicine